Skip to main content
Orchard Therapeutics plc (ORTX)
Jan 24, 2024 - ORTX was delisted (reason: acquired by Kyowa Kirin)
16.70
0.00 (0.00%)
Inactive · Last trade price on Jan 23, 2024

Orchard Therapeutics Revenue

Orchard Therapeutics had revenue of $6.30M in the quarter ending September 30, 2023, with 9.09% growth. This brings the company's revenue in the last twelve months to $21.84M, up 35.21% year-over-year. In the year 2022, Orchard Therapeutics had annual revenue of $22.66M with 1,252.54% growth.

Revenue (ttm)
$21.84M
Revenue Growth
+35.21%
P/S Ratio
n/a
Revenue / Employee
$131,560
Employees
166
Market Cap
n/a

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202222.66M20.98M1,252.54%
Dec 31, 20211.68M-920.00K-35.45%
Dec 31, 20202.60M82.00K3.26%
Dec 31, 20192.51M437.00K21.05%
Dec 31, 20182.08M--
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ORTX News

More News